1.Lateral and posterior single cage combined with unilateral pedicle screw fixation for lumbar degenerative disease
Dongxue YAN ; Yongji HUANG ; Guangbin MA ; Jun LUO ; Junzu HU ; Rongchi XIAO
Chinese Journal of Tissue Engineering Research 2014;(4):541-546
BACKGROUND:Most of lumbar degenerative diseases, such as lumbar instability, lumbar disc herniation and discogenic lumbago, need lumbar spinal fusion for the spine stability, but the choice of internal fixation approaches is controversial.
OBJECTIVE:To compare the effectiveness between lateral lumbar interbody fusion with single cage and single cage combined with unilateral pedicle screw fixation for the 4th and 5th single-level lumbar degenerative disease.
METHODS:The clinical data of patients with single-level lumbar degenerative diseases (L4 and L5) undergoing lateral lumbar interbody fusion with single cage in 30 cases (experimental group) and single cage combined with unilateral pedicle screw fixation in 45 cases (control group) were analyzed retrospectively, and the curative effects were compared between the two groups.
RESULTS AND CONCLUSION:Al patients in the two groups were fol owed up for 13 months on average (ranged from 10 to 37 months). The incisions in the two groups were stage I healing. One case in the experimental group occurred cage displacement, but no obvious syndromes were detected. No significant difference in the effective rate after operation, hospital stay, and volume of drainage was detected (P>0.05). The operative time and bleeding volume in experimental group were better than those in the control group (P<0.05). ODI and JOA scores were significantly improved after treatment when compared with preoperative ones in the two groups (P<0.05), but no significant difference was visible between the two groups (P>0.05). The effectiveness of lateral lumbar interbody fusion with single cage and single cage combined with unilateral pedicle screw fixation for single-level degenerative lumbar diseases was similar. However, the former has the advantages of less invasion and quick recovery.
2.Influence of intraoperative implantation of radioactive (125)I seeds on healing of surgical anastomosis.
Wangkou MA ; Yongji LUO ; Zhonghua CAO ; Weirong ZHANG ; Kuichang ZOU ; Lijun DIAO ; Jun FU
Chinese Journal of Surgery 2002;40(11):860-861
OBJECTIVETo investigate the influence of intraoperative implantation of radioactive (125)I seeds on healing of surgical anastomosis.
METHODSThe jejunum was cut, and end-to-end anastomosis was made in 12 healthy dogs. In the experimental group (n = 8), the (125)I seeds were implanted into the two sides of the anastomosis. The total radiation dosage at the anastomosis was 116 Gy. The other 4 dogs were in the included control group. At the 7th, 14th postoperative day, specimens were obtained from 4 dogs in the experimental group and 2 dogs in the control group respectively. The healing of the anastomosis was observed grossly; hydroxyproline content, as well as histopathological and ultrastructural changes of the anastomotic tissue were studied.
RESULTSGross observation showed healing of the anastomosis of the experimental animals. The hydroxyproline contents were 0.578 +/- 0.020 microg/mg proteins in the experimental group and 0.631 +/- 0.012 microg/mg proteins in the control group (P > 0.05). Histopathological and ultrastructural changes of the anastomotic tissue were not significant in healing as compared to the control group. One of 29 patients had anastomotic leakage.
CONCLUSIONSIntraoperative implantation of (125)I has no adverse effect on healing of surgical anastomosis; it is safe and feasible in clinical practice.
Adult ; Aged ; Anastomosis, Surgical ; Animals ; Brachytherapy ; Dogs ; Female ; Humans ; Intraoperative Care ; Iodine Radioisotopes ; pharmacology ; therapeutic use ; Male ; Middle Aged ; Models, Animal ; Neoplasms ; drug therapy ; Wound Healing ; drug effects
3.Process in menstrual blood-derived mesenchymal stem cells for treatment of central nervous system diseases.
Mengmeng LIU ; Xinran CHENG ; Kaikai LI ; Mingrui XU ; Yongji WU ; Mengli WANG ; Qianru ZHANG ; Wenyong YAN ; Chang LUO ; Shanting ZHAO
Chinese Journal of Biotechnology 2018;34(5):644-652
Stem cell research has become a frontier in the field of life sciences, and provides an ideal model for exploring developmental biology problems such as embryogenesis, histiocytosis, and gene expression regulation, as well as opens up new doors for clinical tissue defective and inheritance diseases. Among them, menstrual blood-derived stem cells (MenSCs) are characterized by wide source, multi-directional differentiation potential, low immune rejection characteristics. Thus, MenSCs can achieve individual treatment and have the most advantage of the clinical application. The central nervous system, including brain and spinal cord, is susceptible to injury. And lethality and morbidity of them tops the list of all types of trauma. Compared to peripheral nervous system, recovery of central nervous system after damage remains extremely hard. However, the treatment of stem cells, especially MenSCs, is expected to solve this problem. Therefore, biological characteristics of MenSCs and their treatment in the respect of central nervous system diseases have been reviewed at home and abroad in recent years, so as to provide reference for the treatment of central nervous system diseases.
4.Surface modification of PGP for a neutrophil-nanoparticle co-vehicle to enhance the anti-depressant effect of baicalein.
Baoyu CHEN ; Man LUO ; Jianming LIANG ; Chun ZHANG ; Caifang GAO ; Jue WANG ; Jianxin WANG ; Yongji LI ; Desheng XU ; Lina LIU ; Ning ZHANG ; Huijun CHEN ; Jing QIN
Acta Pharmaceutica Sinica B 2018;8(1):64-73
Exploiting cells as vehicles combined with nanoparticles combined with therapy has attracted increasing attention in the world recently. Red blood cells, leukocytes and stem cells have been used for tumor immunotherapy, tissue regeneration and inflammatory disorders, and it is known that neutrophils can accumulate in brain lesions in many brain diseases including depression. -Acetyl Pro-Gly-Pro (PGP) peptide shows high specific binding affinity to neutrophils through the CXCR2 receptor. In this study, PGP was used to modify baicalein-loaded solid lipid nanoparticles (PGP-SLNs) to facilitate binding to neutrophils . Brain-targeted delivery to the basolateral amygdala (BLA) was demonstrated by enhanced concentration of baicalein in the BLA. An enhanced anti-depressant effect was observed and The mechanism involved inhibition of apoptosis and a decrease in lactate dehydrogenase release. Behavioral evaluation carried out with rats demonstrated that anti-depression outcomes were achieved. The results indicate that PGP-SLNs decrease immobility time, increase swimming time and climbing time and attenuate locomotion in olfactory-bulbectomized (OB) rats. In conclusion, PGP modification is a strategy for targeting the brain with a cell-nanoparticle delivery system for depression therapy.